Navigation Links
State-of-the Art in Alzheimer's Research Featured at 25th Conference of Alzheimer's Disease International
Date:3/4/2010

LONDON, March 4, 2010 /PRNewswire/ -- "What's new" in Alzheimer's disease medical treatments and diagnosis is the focus of the first day's plenary sessions at the 25th International Conference of Alzheimer's Disease International (ADI), March 11, 2010 at the Grand Hotel Palace, Thessaloniki, Greece.

Sam Gandy, M.D., Ph.D. of Mount Sinai Alzheimer's Disease Research Center, New York, will address "New Treatment Developments" in Alzheimer's, including therapies that have the greatest potential for entering clinical practice in the next few years - bapineuzumab, latrepirdine, and gamma secretase inhibitors. He also will touch on intriguing science that may explain the link between Alzheimer's and diabetes.

"Neuroimaging Perspectives" is the topic of Prof. Frank Jessen of the University of Bonn, Germany. The presentation will cover recent advances in both magnetic resonance imaging (MRI) and positron emission tomography (PET) in Alzheimer's. In particular, how the two technologies have contributed substantially to both better diagnosis and understanding the progression of the disease.

Pieter Jelle Visser, M.D. of Maastricht University Medical Centre and VU University Medical Centre, Amsterdam, The Netherlands will cover "MCI and the Early Diagnosis of Alzheimer's Disease." Mild cognitive impairment (MCI) refers to cognitive impairment not severe enough to meet the criteria of dementia. Using biomarkers and cognitive testing, it is possible to estimate the risk that a person with MCI will progress to Alzheimer's. Visser will provide an overview of markers for Alzheimer's in people with MCI and discuss how they may prove useful in clinical research, earlier diagnosis and treatment.

Bengt Winblad, M.D., Ph.D., of the Karolinska Institutet, Stockholm and Karolinska University, Huddinge, Sweden, will speak on "Ongoing clinical trials in Alzheimer's disease."

The day's second plenary session will focus on the "Global Alzheimer's Movement." Other plenaries will focus on treatments without drugs, and best practices in dementia care. For more information, visit http://www.adi2010.org/

ADI is working closely with the Greek Association of Alzheimer's Disease and Related Disorders in organizing this conference.

Alzheimer's Disease International is an international federation of 71 Alzheimer associations around the world, in official relations with the World Health Organization. ADI's mission is to improve the quality of life of people with dementia and their families throughout the world. Please visit http://www.alz.co.uk/adi/.

Contacts:

Niles Frantz, Alzheimer's Association (Chicago), +1-312-335-5777, niles.frantz@alz.org

Marc Wortmann, Alzheimer's Disease International (London), +44-20-7981-0880, m.wortmann@alz.co.uk

SOURCE Alzheimer's Disease International

Back to top
'/>"/>
SOURCE Alzheimer's Disease International
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. A Top Cosmetic Dentistry Practice in Central New Jersey Announces Launch of New, State-of-the-Art Website
2. New Provider of Tablet/Capsule Packaging Solutions For Offers State-of-the-Art Equipment In The United States & Mexico
3. Long Island Plastic Surgical Practice - the Largest in the U.S. - Opens Virtual Doors on a New, State-of-the-Art Website
4. UCSF Medical Center Orders Three RIVA Systems for State-of-the-Art Pharmacy Facility
5. Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care
6. Epilepsy patients caught in treatment gap are not getting state-of-the-art care
7. Richmond, Virginia Plastic Surgeon Launches State-of-the-Art Breast Surgery Website
8. Bay Area Plastic Surgeon Reaches Out to Patients with New, State-of-the-Art Website
9. Nicky Hambleton-Jones Supports Launch of State-of-the-Art London Cosmetic Surgery Clinic
10. LASIK Eye Surgeons in San Diego Announce Launch of New, State-of-the-Art Website
11. The Help Group Summit on Autism, Learning Disabilities, and ADHD Features State-of-the-Art Research and Best Practices in Education and Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... N.Y (PRWEB) , ... October 13, 2017 , ... Lori ... became a member of ElderCounsel, a national organization of elder law and special needs ... changing laws and rules. It also provides a forum to network with elder law ...
(Date:10/13/2017)... Milford, NJ (PRWEB) , ... October 13, 2017 , ... ... weekend at scenic Alexandria Park in Milford, NJ. This free event, sponsored by ... and physical activity. The fun run is geared towards children of all ages; ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history ... The Brink” is the creation of published author, William Nowers. Captain Nowers and ... WWII veteran, he spent thirty years in the Navy. Following his career as ...
(Date:10/12/2017)... , ... October 12, 2017 , ... IsoComforter, Inc. ( ... announced today the introduction of an innovative new design of the shoulder pad. ... you get maximum comfort while controlling your pain while using cold therapy. By utilizing ...
(Date:10/12/2017)... ... , ... HMP , a leader in healthcare events and education, today announced ... Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie ... competition recognizes editorial and design excellence across a range of sectors. This year’s program ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Oct. 2, 2017 Halo Labs announces the European launch ... called the HORIZON at MIBio 2017 in Cambridge, U.K ... visible particulate matter in biopharmaceutical samples with unprecedented speed and sensitivity ... novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
(Date:9/27/2017)... 2017  Commended for their devotion to personalized service, SMP ... number one in the South Florida Business Journal,s 50 Fastest-Growing ... yearly list, the national specialty pharmacy has found its niche.  ... will soon be honored by SFBJ as the 2017 Power ... Set to receive his award in October, Bardisa said of ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, ... complete response letter from the U.S. Food and Drug ... approval of sirukumab for the treatment of moderately to ... indicates additional clinical data are needed to further evaluate ... to severely active RA. ...
Breaking Medicine Technology: